Innoviva closes sale of 750 Class A and 750 Class C units of Theravance Respiratory to Royalty Pharma

Innoviva, Inc.

Closed sale of 750 Class A and 750 Class C units of Theravance Respiratory Company, LLC to Royalty Pharma Investments 2019 ICAV.
Closing date was July 20, 2022, as previously announced on July 13, 2022.
The seller was Innoviva, Inc. and its wholly-owned subsidiary Innoviva TRC Holdings LLC.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.